Table 2.
HF |
LF |
SDNN |
|
---|---|---|---|
Beta (CI) | Beta (CI) | Beta (CI) | |
(a) Non-clinical sample | |||
BMI | 0.12 (−0.16 to 0.40) ns | −0.19 (−0.47 to 0.09) ns | −0.05 (−0.33 to 0.23) ns |
p-glucose | −0.01 (−0.27 to 0.25) ns | 0.00 (−0.27 to 0.26) ns | −0.06 (−0.32 to 0.21) ns |
SBP | 0.06 (−0.26 to 0.38) ns | 0.23 (−0.09 to 0.55) ns | 0.13 (−0.19 to 0.45) ns |
DBP | −0.37 (−0.68 to −0.07) | −0.35 (−0.66 to −0.04) | −0.41 (−0.71 to 0.10) |
Physical activity | 0.35 (0.09 to 0.61) | 0.30 (0.04 to 0.56) | 0.31 (0.05 to 0.56) |
(b) Clinical sample | |||
BMI | −0.03 (−0.32 to 0.27) ns | −0.25 (−0.53 to 0.03) ns | −0.22 (−0.50 to 0.07) ns |
p-glucose | −0.05 (−0.36 to 0.26) ns | 0.04 (−0.25 to 0.34) ns | 0.07 (−0.24 to 0.37) ns |
SBP | −0.12 (−0.49 to 0.26) ns | −0.11 (−0.48 to 0.25) ns | −0.10 (−0.47 to 0.27) ns |
DBP | 0.02 (−0.37 to 0.41) ns | 0.14 (−0.23 to 0.51) ns | 0.05 (−0.33 to 0.43) ns |
Physical activity | −0.07 (−0.36 to 0.23) ns | −0.12 (−0.40 to 0.16) ns | −0.08 (−0.36 to 0.21) ns |